The problem with potency
- 31 August 2005
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 23 (9) , 1037-1039
- https://doi.org/10.1038/nbt0905-1037
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy and Natalizumab — Unforeseen ConsequencesNew England Journal of Medicine, 2005
- Blocking adhesion molecules as therapy for multiple sclerosis: natalizumabNature Reviews Drug Discovery, 2005
- Third Tysabri adverse case hits drug classNature Reviews Drug Discovery, 2005
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaProceedings of the National Academy of Sciences, 2003
- Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathyProceedings of the National Academy of Sciences, 2002
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992